F. Oshita et A. Eastman, GENE-SPECIFIC DAMAGE PRODUCED BY CISPLATIN, ORMAPLATIN AND UV-LIGHT IN HUMAN-CELLS AS ASSAYED BY THE POLYMERASE CHAIN-REACTION, Oncology research, 5(3), 1993, pp. 111-118
The level of DNA damage in the total genome of leukocytes from patient
s receiving cisplatin therapy has been previously correlated with ther
apeutic outcome. Based on the fact that unrepaired damage in transcrib
ed genes has been well correlated with sensitivity to a number of DNA
damaging agents, the correlations with therapeutic response might be i
mproved if the level of DNA damage in specific genes was assessed. We
previously established a polymerase chain reaction (PCR)-based assay t
o measure cisplatin lesions in specific genes. The major advantages of
this assay include its potential to quantify DNA lesions produced by
any DNA damaging agent, and to measure it in minute samples of cells.
This assay has been further improved to realize this potential. Specif
ically, cells were damaged with cisplatin, a related analogue ormaplat
in, and ultraviolet light, and PCR was performed on the DNA from 1000
cells after direct lysis with no purification. Human HL-60 cells were
used to compare the efficacy of the various agents to damage the alpha
-fetoprotein gene. This was then extrapolated to damage in the total g
enome and compared to the cytotoxicity for each agent. At a dose that
killed 50% of the cells, ormaplatin, cisplatin and ultraviolet light p
roduced 19,200, 48,000, and 1,080,000 lesions per cell, demonstrating
that ormaplatin lesions were the most effective at killing cells. Mono
nuclear cells were obtained from freshly isolated blood from five indi
viduals. These cells were damaged with the three agents, and PCR of th
e alpha-fetoprotein gene was performed. No significant difference betw
een the individuals was observed in the level of DNA damage produced b
y any of the agents. The results show that this is a rapid and facile
assay for quantitation of DNA damage in very small numbers of cells, a
nd is particularly applicable to analysis of DNA damage in freshly iso
lated human blood.